1. Petterson E. IgA nephropathy: 30 years on. J Intern Med 1997; 242: 349-53.
2. Yoshikawa N, Tanaka R, Iijima K. Pathophysiology and treatment of IgA nephropathy in children. Pediatr Nephrol (2001) 16: 446-457.
3. Matousovic K, Martinek V. IgA nephropathy. Use of modern laboratory methods and renal biopsy for diagnosis. Vnitr Lek. 2003 Nov;49(11):869-73.
4. Wyatt RJ, Keitchevsky SB, Woodford SY, Miller PM, Roy S 3rd Holland NH, Jackson E, Bishof NA. IgA Nephropathy: long-term prognosis for pediatric patients. J Pediatric 1995; 127: 913-919.
5. Sakai H. Current views on pathogenesis and treatment. In: Andreucci VE (ed) International Year Book of Nephrology. Kluwer, Boston, 1989; pp 23-46.
6. Allen AC, Feehally J. IgA 1 glycosylation and the pathogenesis of IgA nephropathy. Am J Kidney Dis 2000; 35: 551-556.
7. Valentijin RM, Radl J, Haayman JJ, Vermeer BJ, Weening JJ, Kauffmann RH, Daha MR, Es La van. Macromolecular IgA in the circulation and mesangial deposits in patients with primary IgA nephropathy. Contrib Nephrol 1984; 40: 87-92.
8. Schena FP. A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 1990; 89: 209-15.
9. Julian BA, Bryson Waldo F, Rifai A, Mestecky J. IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am J Med, 1988; 129-32.
10. Bogenschutz O, Bohle A, Batz C, Wehrmann M, Pressler H, Kendziorra H, Gartner HV. IgA nephritis: on the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am J Nephrol 1990; 10: 137-47.
11. Decramer S. Berger's disease in childhood Arch Pediatr. 2002 May;9(5):519-29.
12. Galla JH, Perspectives in clinical nephropathy. IgA nephropathy. Kidney Int 1995; 47: 377-87.
13. Schena FP, Montenegro M, Scivitarro V. Meta-analysis of randomised controlled trials in patients with primary IgA nephropathy (Berger´s Disease). Nephrol Dial Transplant 1990; 5 (suppl.1): 47-52.